Drug resistance in newly diagnosed tuberculosis patients
Part of Infections clinical trials.
This study looks at whether TB bacteria are resistant to the drugs used for treatment. It helps doctors understand which medicines work best for newly diagnosed patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have just been diagnosed with tuberculosis (TB).
- Your diagnosis must be confirmed by a sputum (phlegm) or body fluid test.
- You have not had treatment for TB before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new “triple-dose” set of medicines to treat people whose tuberculosis (TB) has come back in the lungs. If you qualify, the goal is to improve cure rates and reduce the chance of TB returning again.
This study tests rapid TB screening and lab-style diagnostic methods to see how well they find TB disease and TB that is resistant to rifampin (a key TB drug). It may help doctors diagnose TB faster and more accurately, especially in people at higher risk.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
This trial tests how quickly two antibiotics (tedizolid vs linezolid) can kill tuberculosis germs in the lungs after a first TB infection is suspected. It may help doctors learn which option works faster and safely in the early treatment phase.
This study looks at how tuberculosis bacteria become resistant to drugs. If you have tested positive for TB, this study might help find better treatments for resistant TB.
This study tests whether using a detailed sputum test to guide treatment for drug-resistant tuberculosis (TB) leads to better outcomes. Participants' treatment is tailored based on the specific drug resistance found, which may help them recover faster and reduce side effects.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.